METAVISTA 3D INC (DDD.CA) Stock Fundamental Analysis

TSX-V:DDD • CA59142H1073

0.75 CAD
+0.05 (+7.14%)
Last: Feb 23, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DDD. DDD was compared to 15 industry peers in the Electronic Equipment, Instruments & Components industry. DDD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DDD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • DDD had negative earnings in the past year.
  • DDD had a negative operating cash flow in the past year.
DDD.CA Yearly Net Income VS EBIT VS OCF VS FCFDDD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • DDD has a worse Return On Assets (-571.77%) than 93.33% of its industry peers.
  • Looking at the Return On Equity, with a value of -750.51%, DDD is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -571.77%
ROE -750.51%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DDD.CA Yearly ROA, ROE, ROICDDD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -200 -400

1.3 Margins

  • DDD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DDD.CA Yearly Profit, Operating, Gross MarginsDDD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The number of shares outstanding for DDD remains at a similar level compared to 1 year ago.
  • DDD has a better debt/assets ratio than last year.
DDD.CA Yearly Shares OutstandingDDD.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
DDD.CA Yearly Total Debt VS Total AssetsDDD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

  • DDD has an Altman-Z score of 35.00. This indicates that DDD is financially healthy and has little risk of bankruptcy at the moment.
  • DDD's Altman-Z score of 35.00 is amongst the best of the industry. DDD outperforms 93.33% of its industry peers.
  • DDD has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • DDD has a Debt to Equity ratio of 0.13. This is in the better half of the industry: DDD outperforms 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 35
ROIC/WACCN/A
WACCN/A
DDD.CA Yearly LT Debt VS Equity VS FCFDDD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M 2M 3M

2.3 Liquidity

  • A Current Ratio of 4.20 indicates that DDD has no problem at all paying its short term obligations.
  • DDD's Current ratio of 4.20 is fine compared to the rest of the industry. DDD outperforms 73.33% of its industry peers.
  • DDD has a Quick Ratio of 4.20. This indicates that DDD is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 4.20, DDD is doing good in the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.2
Quick Ratio 4.2
DDD.CA Yearly Current Assets VS Current LiabilitesDDD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for DDD have decreased strongly by -1684.72% in the last year.
EPS 1Y (TTM)-1684.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-389.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • DDD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DDD.CA Price Earnings VS Forward Price EarningsDDD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DDD.CA Per share dataDDD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2 -0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for DDD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

METAVISTA 3D INC

TSX-V:DDD (2/23/2026, 7:00:00 PM)

0.75

+0.05 (+7.14%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-29
Earnings (Next)04-20
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.61%
Ins Owner ChangeN/A
Market Cap85.36M
Revenue(TTM)1.81M
Net Income(TTM)-28.95M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 47.17
P/FCF N/A
P/OCF N/A
P/B 22.13
P/tB 22.13
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.02
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -571.77%
ROE -750.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.2
Quick Ratio 4.2
Altman-Z 35
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1684.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-389.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-727.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-603.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-603.96%
OCF growth 3YN/A
OCF growth 5YN/A

METAVISTA 3D INC / DDD.CA FAQ

Can you provide the ChartMill fundamental rating for METAVISTA 3D INC?

ChartMill assigns a fundamental rating of 2 / 10 to DDD.CA.


What is the valuation status for DDD stock?

ChartMill assigns a valuation rating of 0 / 10 to METAVISTA 3D INC (DDD.CA). This can be considered as Overvalued.


Can you provide the profitability details for METAVISTA 3D INC?

METAVISTA 3D INC (DDD.CA) has a profitability rating of 0 / 10.


What is the financial health of METAVISTA 3D INC (DDD.CA) stock?

The financial health rating of METAVISTA 3D INC (DDD.CA) is 6 / 10.